In the fight against devastating disease, risk-sharing agreements between payers and manufacturers of costly drugs to enable access to new medication, is slowly gaining prevalence in the region, writes Husam Majaly. Healthcare costs have been increasing continuously in the last two to three decades, even at double-digit rates in some markets. The public and private […]
To continue reading this article, Existing users can sign in / subscribe / renew and new users are requested to register.
